GlaxoSmithKline hopes to trigger more research into the fight against AIDS with a series of $500,000 grants.

GSK, which announced the plan Thursday, said researchers can apply for the grants for work in areas of therapies aimed at treating infection, prophylactic vaccines and microbicides designed to prevent transmission of HIV.

Grants range from $25,000 to $150,000. Application deadline is July 31.

For information on the grants, go to:

GSK has awarded drug discovery and development research grants since 2001.